Veracyte to buy Israeli cancer detection co C2i Genomics
The US cancer diagnostics company will pay up to $95 million for C2i Genomics, which has raised $112 million.
Stay updated with breaking news from Boris Oklander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US cancer diagnostics company will pay up to $95 million for C2i Genomics, which has raised $112 million.
Automat-IT today announced a multi-year Strategic Collaboration Agreement with Amazon Web Services, Inc. (AWS), benefiting customers in Europe and Israel with cutting edge digital services. Automat-IT
AWS has launched general availability for Amazon Omics, which helps researchers store and analyze omic data like sequences of DNA, RNA and proteins.
The startups were named to the Digital Health 150, an annual ranking of companies using digital tech to transform the healthcare industry.
A new genomic platform uses AI to enable doctors to find mutations signifying persistent or recurrent cancer cells months or years before current technologies.